Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORMD-0801 in T2DM inadequately controlled with metformin
NCT02496000Phase 2Completed
- Sponsor
- Oramed Pharmaceuticals Inc.
- Start
- Jul 2015
- Primary completion
- Jun 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ORMD-0801 in type 2 diabetes mellitus (T2DM), sponsored by Oramed Pharmaceuticals Inc.. Started Jul 2015; status: completed.
02
Drugs
ORMD-0801
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02496000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496000.